207 related articles for article (PubMed ID: 20303954)
1. Protection against murine intestinal amoebiasis induced by oral immunization with the 29 kDa antigen of Entamoeba histolytica and cholera toxin.
Carrero JC; Contreras-Rojas A; Sánchez-Hernández B; Petrosyan P; Bobes RJ; Ortiz-Ortiz L; Laclette JP
Exp Parasitol; 2010 Nov; 126(3):359-65. PubMed ID: 20303954
[TBL] [Abstract][Full Text] [Related]
2. The role of the secretory immune response in the infection by Entamoeba histolytica.
Carrero JC; Cervantes-Rebolledo C; Aguilar-Díaz H; Díaz-Gallardo MY; Laclette JP; Morales-Montor J
Parasite Immunol; 2007 Jul; 29(7):331-8. PubMed ID: 17576362
[TBL] [Abstract][Full Text] [Related]
3. Local and systemic antibody response in Balb/c mice immunized with Entamoeba histolytica trophozoites.
Villareall BB; Melendro EI; Ramos F; Ximénez C
Arch Med Res; 1992; 23(1):69-72. PubMed ID: 1308795
[TBL] [Abstract][Full Text] [Related]
4. Immunodulation of rat serum and mucosal antibody responses to Entamoeba histolytica trophozoites by beta-1,3-glucan and cholera toxin.
Navarro-García F; Pedroso M; López-Revilla R
Clin Immunol; 2000 Nov; 97(2):182-8. PubMed ID: 11027459
[TBL] [Abstract][Full Text] [Related]
5. Oral immunization with the dodecapeptide repeat of the serine-rich Entamoeba histolytica protein (SREHP) fused to the cholera toxin B subunit induces a mucosal and systemic anti-SREHP antibody response.
Zhang T; Li E; Stanley SL
Infect Immun; 1995 Apr; 63(4):1349-55. PubMed ID: 7890393
[TBL] [Abstract][Full Text] [Related]
6. Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.
Kundu J; Mazumder R; Srivastava R; Srivastava BS
FEMS Immunol Med Microbiol; 2009 Jul; 56(2):179-84. PubMed ID: 19453752
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and protective efficacy of heparan sulphate binding proteins of Entamoeba histolytica in a guinea pig model of intestinal amoebiasis.
Kaur U; Khurana S; Saikia UN; Dubey ML
Exp Parasitol; 2013 Nov; 135(3):486-96. PubMed ID: 24007700
[TBL] [Abstract][Full Text] [Related]
8. Mapping of B epitopes in GRA4, a dense granule antigen of Toxoplasma gondii and protection studies using recombinant proteins administered by the oral route.
Mévélec MN; Mercereau-Puijalon O; Buzoni-Gatel D; Bourguin I; Chardès T; Dubremetz JF; Bout D
Parasite Immunol; 1998 Apr; 20(4):183-95. PubMed ID: 9618729
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of a Gal-lectin subunit vaccine against experimental Entamoeba histolytica infection and colitis in baboons (Papio sp.).
Abd Alla MD; Wolf R; White GL; Kosanke SD; Cary D; Verweij JJ; Zhang MJ; Ravdin JI
Vaccine; 2012 Apr; 30(20):3068-75. PubMed ID: 22406457
[TBL] [Abstract][Full Text] [Related]
10. Role of mucosal secretory immunity in the development of an amebiasis vaccine.
Ravdin JI; Kelsall BL
Am J Trop Med Hyg; 1994; 50(5 Suppl):36-41. PubMed ID: 8203722
[TBL] [Abstract][Full Text] [Related]
11. Intestinal amoebiasis: antibody-secreting cells and humoral antibodies.
Ghosh PK; Gupta S; Leon LR; Ghosh R; Ruiz Ordaz BH; Ortiz-Ortiz L
J Diarrhoeal Dis Res; 1998 Mar; 16(1):1-7. PubMed ID: 9775574
[TBL] [Abstract][Full Text] [Related]
12. Adherence-inhibitory intestinal immunoglobulin a antibody response in baboons elicited by use of a synthetic intranasal lectin-based amebiasis subunit vaccine.
Abd Alla MD; White GL; Rogers TB; Cary ME; Carey DW; Ravdin JI
Infect Immun; 2007 Aug; 75(8):3812-22. PubMed ID: 17526742
[TBL] [Abstract][Full Text] [Related]
13. Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.
Cong H; Gu QM; Jiang Y; He SY; Zhou HY; Yang TT; Li Y; Zhao QL
Parasite Immunol; 2005; 27(1-2):29-35. PubMed ID: 15813720
[TBL] [Abstract][Full Text] [Related]
14. Mucosal immunogenicity of a holotoxin-like molecule containing the serine-rich Entamoeba histolytica protein (SREHP) fused to the A2 domain of cholera toxin.
Sultan F; Jin LL; Jobling MG; Holmes RK; Stanley SL
Infect Immun; 1998 Feb; 66(2):462-8. PubMed ID: 9453596
[TBL] [Abstract][Full Text] [Related]
15. Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits.
Hajishengallis G; Hollingshead SK; Koga T; Russell MW
J Immunol; 1995 May; 154(9):4322-32. PubMed ID: 7722290
[TBL] [Abstract][Full Text] [Related]
16. Production of IgE antibody and allergic sensitization of intestinal and peripheral tissues after oral immunization with protein Ag and cholera toxin.
Snider DP; Marshall JS; Perdue MH; Liang H
J Immunol; 1994 Jul; 153(2):647-57. PubMed ID: 8021502
[TBL] [Abstract][Full Text] [Related]
17. Combined oral/nasal immunization protects mice from Sendai virus infection.
Nedrud JG; Liang XP; Hague N; Lamm ME
J Immunol; 1987 Nov; 139(10):3484-92. PubMed ID: 2824609
[TBL] [Abstract][Full Text] [Related]
18. Peroral immunization with Helicobacter pylori adhesin protein genetically linked to cholera toxin A2B subunits.
Kim BO; Shin SS; Yoo YH; Pyo S
Clin Sci (Lond); 2001 Mar; 100(3):291-8. PubMed ID: 11222115
[TBL] [Abstract][Full Text] [Related]
19. Immunization with the Entamoeba histolytica surface metalloprotease EhMSP-1 protects hamsters from amebic liver abscess.
Roncolato EC; Teixeira JE; Barbosa JE; Zambelli Ramalho LN; Huston CD
Infect Immun; 2015 Feb; 83(2):713-20. PubMed ID: 25452550
[TBL] [Abstract][Full Text] [Related]
20. Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus.
Liang XP; Lamm ME; Nedrud JG
J Immunol; 1988 Sep; 141(5):1495-501. PubMed ID: 2842395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
